TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Companion Animal Vaccines Market Insights, Forecast to 2028

Global Companion Animal Vaccines Market Insights, Forecast to 2028

  • Category:Life Sciences
  • Published on : 24 July 2022
  • Pages :90
  • Formats:
  • Report Code:SMR-7230490
OfferClick for best price

Best Price: $3920

Companion Animal Vaccines Market Size, Share 2022


Market Analysis and Insights: Global Companion Animal Vaccines Market

The global Companion Animal Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Companion Animal Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Companion Animal Vaccines market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Companion Animal Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Companion Animal Vaccines market.

Global Companion Animal Vaccines Scope and Market Size

Companion Animal Vaccines market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Companion Animal Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Attenuated Live Vaccines

Conjugate Vaccines

Inactivated Vaccines

Subunit Vaccines

Toxoid Vaccines

DNA Vaccines

Recombinant Vaccines

Segment by Application

Canine

Avian

Feline

By Company

Bayer

Vetoquinol

Boehringer Ingelheim

Ceva

Eli Lilly

Heska

Merck

Merial

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Companion Animal Vaccines product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Companion Animal Vaccines, with price, sales, revenue, and global market share of Companion Animal Vaccines from 2019 to 2022.

Chapter 3, the Companion Animal Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Companion Animal Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Companion Animal Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Companion Animal Vaccines.

Chapter 13, 14, and 15, to describe Companion Animal Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Companion Animal Vaccines Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Companion Animal Vaccines Market Insights, Forecast to 2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 90 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Companion Animal Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Companion Animal Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Attenuated Live Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Inactivated Vaccines
1.2.5 Subunit Vaccines
1.2.6 Toxoid Vaccines
1.2.7 DNA Vaccines
1.2.8 Recombinant Vaccines
1.3 Market by Application
1.3.1 Global Companion Animal Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Canine
1.3.3 Avian
1.3.4 Feline
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Companion Animal Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Companion Animal Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Companion Animal Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Companion Animal Vaccines Sales by Region
2.4.1 Global Companion Animal Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Companion Animal Vaccines by Region (2023-2028)
2.5 Global Companion Animal Vaccines Revenue by Region
2.5.1 Global Companion Animal Vaccines Revenue by Region (2017-2022)
2.5.2 Global Companion Animal Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Companion Animal Vaccines Sales by Manufacturers
3.1.1 Global Top Companion Animal Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Companion Animal Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Companion Animal Vaccines in 2021
3.2 Global Companion Animal Vaccines Revenue by Manufacturers
3.2.1 Global Companion Animal Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Companion Animal Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Companion Animal Vaccines Revenue in 2021
3.3 Global Companion Animal Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Companion Animal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Companion Animal Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Companion Animal Vaccines Sales by Type
4.1.1 Global Companion Animal Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Companion Animal Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Companion Animal Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Companion Animal Vaccines Revenue by Type
4.2.1 Global Companion Animal Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Companion Animal Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Companion Animal Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Companion Animal Vaccines Price by Type
4.3.1 Global Companion Animal Vaccines Price by Type (2017-2022)
4.3.2 Global Companion Animal Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Companion Animal Vaccines Sales by Application
5.1.1 Global Companion Animal Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Companion Animal Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Companion Animal Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Companion Animal Vaccines Revenue by Application
5.2.1 Global Companion Animal Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Companion Animal Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Companion Animal Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Companion Animal Vaccines Price by Application
5.3.1 Global Companion Animal Vaccines Price by Application (2017-2022)
5.3.2 Global Companion Animal Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Companion Animal Vaccines Market Size by Type
6.1.1 North America Companion Animal Vaccines Sales by Type (2017-2028)
6.1.2 North America Companion Animal Vaccines Revenue by Type (2017-2028)
6.2 North America Companion Animal Vaccines Market Size by Application
6.2.1 North America Companion Animal Vaccines Sales by Application (2017-2028)
6.2.2 North America Companion Animal Vaccines Revenue by Application (2017-2028)
6.3 North America Companion Animal Vaccines Market Size by Country
6.3.1 North America Companion Animal Vaccines Sales by Country (2017-2028)
6.3.2 North America Companion Animal Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Companion Animal Vaccines Market Size by Type
7.1.1 Europe Companion Animal Vaccines Sales by Type (2017-2028)
7.1.2 Europe Companion Animal Vaccines Revenue by Type (2017-2028)
7.2 Europe Companion Animal Vaccines Market Size by Application
7.2.1 Europe Companion Animal Vaccines Sales by Application (2017-2028)
7.2.2 Europe Companion Animal Vaccines Revenue by Application (2017-2028)
7.3 Europe Companion Animal Vaccines Market Size by Country
7.3.1 Europe Companion Animal Vaccines Sales by Country (2017-2028)
7.3.2 Europe Companion Animal Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Companion Animal Vaccines Market Size by Type
8.1.1 Asia Pacific Companion Animal Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Companion Animal Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Companion Animal Vaccines Market Size by Application
8.2.1 Asia Pacific Companion Animal Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Companion Animal Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Companion Animal Vaccines Market Size by Region
8.3.1 Asia Pacific Companion Animal Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Companion Animal Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Companion Animal Vaccines Market Size by Type
9.1.1 Latin America Companion Animal Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Companion Animal Vaccines Revenue by Type (2017-2028)
9.2 Latin America Companion Animal Vaccines Market Size by Application
9.2.1 Latin America Companion Animal Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Companion Animal Vaccines Revenue by Application (2017-2028)
9.3 Latin America Companion Animal Vaccines Market Size by Country
9.3.1 Latin America Companion Animal Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Companion Animal Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Companion Animal Vaccines Market Size by Type
10.1.1 Middle East and Africa Companion Animal Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Companion Animal Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Companion Animal Vaccines Market Size by Application
10.2.1 Middle East and Africa Companion Animal Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Companion Animal Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Companion Animal Vaccines Market Size by Country
10.3.1 Middle East and Africa Companion Animal Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Companion Animal Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Overview
11.1.3 Bayer Companion Animal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer Companion Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 Vetoquinol
11.2.1 Vetoquinol Corporation Information
11.2.2 Vetoquinol Overview
11.2.3 Vetoquinol Companion Animal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Vetoquinol Companion Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Vetoquinol Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Companion Animal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Boehringer Ingelheim Companion Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Ceva
11.4.1 Ceva Corporation Information
11.4.2 Ceva Overview
11.4.3 Ceva Companion Animal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ceva Companion Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ceva Recent Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Corporation Information
11.5.2 Eli Lilly Overview
11.5.3 Eli Lilly Companion Animal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Eli Lilly Companion Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eli Lilly Recent Developments
11.6 Heska
11.6.1 Heska Corporation Information
11.6.2 Heska Overview
11.6.3 Heska Companion Animal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Heska Companion Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Heska Recent Developments
11.7 Merck
11.7.1 Merck Corporation Information
11.7.2 Merck Overview
11.7.3 Merck Companion Animal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Merck Companion Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck Recent Developments
11.8 Merial
11.8.1 Merial Corporation Information
11.8.2 Merial Overview
11.8.3 Merial Companion Animal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Merial Companion Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merial Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Companion Animal Vaccines Industry Chain Analysis
12.2 Companion Animal Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Companion Animal Vaccines Production Mode & Process
12.4 Companion Animal Vaccines Sales and Marketing
12.4.1 Companion Animal Vaccines Sales Channels
12.4.2 Companion Animal Vaccines Distributors
12.5 Companion Animal Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Companion Animal Vaccines Industry Trends
13.2 Companion Animal Vaccines Market Drivers
13.3 Companion Animal Vaccines Market Challenges
13.4 Companion Animal Vaccines Market Restraints
14 Key Findings in The Global Companion Animal Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Companion Animal Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Attenuated Live Vaccines
Table 3. Major Manufacturers of Conjugate Vaccines
Table 4. Major Manufacturers of Inactivated Vaccines
Table 5. Major Manufacturers of Subunit Vaccines
Table 6. Major Manufacturers of Toxoid Vaccines
Table 7. Major Manufacturers of DNA Vaccines
Table 8. Major Manufacturers of Recombinant Vaccines
Table 9. Global Companion Animal Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Companion Animal Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Companion Animal Vaccines Sales by Region (2017-2022) & (K Units)
Table 12. Global Companion Animal Vaccines Sales Market Share by Region (2017-2022)
Table 13. Global Companion Animal Vaccines Sales by Region (2023-2028) & (K Units)
Table 14. Global Companion Animal Vaccines Sales Market Share by Region (2023-2028)
Table 15. Global Companion Animal Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Companion Animal Vaccines Revenue Market Share by Region (2017-2022)
Table 17. Global Companion Animal Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Companion Animal Vaccines Revenue Market Share by Region (2023-2028)
Table 19. Global Companion Animal Vaccines Sales by Manufacturers (2017-2022) & (K Units)
Table 20. Global Companion Animal Vaccines Sales Share by Manufacturers (2017-2022)
Table 21. Global Companion Animal Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Global Companion Animal Vaccines Revenue Share by Manufacturers (2017-2022)
Table 23. Companion Animal Vaccines Price by Manufacturers (2017-2022) &(USD/Unit)
Table 24. Global Companion Animal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Companion Animal Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Animal Vaccines as of 2021)
Table 26. Companion Animal Vaccines Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Companion Animal Vaccines Product Offered
Table 28. Date of Manufacturers Enter into Companion Animal Vaccines Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Companion Animal Vaccines Sales by Type (2017-2022) & (K Units)
Table 31. Global Companion Animal Vaccines Sales by Type (2023-2028) & (K Units)
Table 32. Global Companion Animal Vaccines Sales Share by Type (2017-2022)
Table 33. Global Companion Animal Vaccines Sales Share by Type (2023-2028)
Table 34. Global Companion Animal Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 35. Global Companion Animal Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 36. Global Companion Animal Vaccines Revenue Share by Type (2017-2022)
Table 37. Global Companion Animal Vaccines Revenue Share by Type (2023-2028)
Table 38. Companion Animal Vaccines Price by Type (2017-2022) & (USD/Unit)
Table 39. Global Companion Animal Vaccines Price Forecast by Type (2023-2028) & (USD/Unit)
Table 40. Global Companion Animal Vaccines Sales by Application (2017-2022) & (K Units)
Table 41. Global Companion Animal Vaccines Sales by Application (2023-2028) & (K Units)
Table 42. Global Companion Animal Vaccines Sales Share by Application (2017-2022)
Table 43. Global Companion Animal Vaccines Sales Share by Application (2023-2028)
Table 44. Global Companion Animal Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 45. Global Companion Animal Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 46. Global Companion Animal Vaccines Revenue Share by Application (2017-2022)
Table 47. Global Companion Animal Vaccines Revenue Share by Application (2023-2028)
Table 48. Companion Animal Vaccines Price by Application (2017-2022) & (USD/Unit)
Table 49. Global Companion Animal Vaccines Price Forecast by Application (2023-2028) & (USD/Unit)
Table 50. North America Companion Animal Vaccines Sales by Type (2017-2022) & (K Units)
Table 51. North America Companion Animal Vaccines Sales by Type (2023-2028) & (K Units)
Table 52. North America Companion Animal Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 53. North America Companion Animal Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 54. North America Companion Animal Vaccines Sales by Application (2017-2022) & (K Units)
Table 55. North America Companion Animal Vaccines Sales by Application (2023-2028) & (K Units)
Table 56. North America Companion Animal Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 57. North America Companion Animal Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 58. North America Companion Animal Vaccines Sales by Country (2017-2022) & (K Units)
Table 59. North America Companion Animal Vaccines Sales by Country (2023-2028) & (K Units)
Table 60. North America Companion Animal Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 61. North America Companion Animal Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 62. Europe Companion Animal Vaccines Sales by Type (2017-2022) & (K Units)
Table 63. Europe Companion Animal Vaccines Sales by Type (2023-2028) & (K Units)
Table 64. Europe Companion Animal Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 65. Europe Companion Animal Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 66. Europe Companion Animal Vaccines Sales by Application (2017-2022) & (K Units)
Table 67. Europe Companion Animal Vaccines Sales by Application (2023-2028) & (K Units)
Table 68. Europe Companion Animal Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 69. Europe Companion Animal Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 70. Europe Companion Animal Vaccines Sales by Country (2017-2022) & (K Units)
Table 71. Europe Companion Animal Vaccines Sales by Country (2023-2028) & (K Units)
Table 72. Europe Companion Animal Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 73. Europe Companion Animal Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 74. Asia Pacific Companion Animal Vaccines Sales by Type (2017-2022) & (K Units)
Table 75. Asia Pacific Companion Animal Vaccines Sales by Type (2023-2028) & (K Units)
Table 76. Asia Pacific Companion Animal Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 77. Asia Pacific Companion Animal Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 78. Asia Pacific Companion Animal Vaccines Sales by Application (2017-2022) & (K Units)
Table 79. Asia Pacific Companion Animal Vaccines Sales by Application (2023-2028) & (K Units)
Table 80. Asia Pacific Companion Animal Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 81. Asia Pacific Companion Animal Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 82. Asia Pacific Companion Animal Vaccines Sales by Region (2017-2022) & (K Units)
Table 83. Asia Pacific Companion Animal Vaccines Sales by Region (2023-2028) & (K Units)
Table 84. Asia Pacific Companion Animal Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 85. Asia Pacific Companion Animal Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 86. Latin America Companion Animal Vaccines Sales by Type (2017-2022) & (K Units)
Table 87. Latin America Companion Animal Vaccines Sales by Type (2023-2028) & (K Units)
Table 88. Latin America Companion Animal Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 89. Latin America Companion Animal Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 90. Latin America Companion Animal Vaccines Sales by Application (2017-2022) & (K Units)
Table 91. Latin America Companion Animal Vaccines Sales by Application (2023-2028) & (K Units)
Table 92. Latin America Companion Animal Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 93. Latin America Companion Animal Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 94. Latin America Companion Animal Vaccines Sales by Country (2017-2022) & (K Units)
Table 95. Latin America Companion Animal Vaccines Sales by Country (2023-2028) & (K Units)
Table 96. Latin America Companion Animal Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 97. Latin America Companion Animal Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Companion Animal Vaccines Sales by Type (2017-2022) & (K Units)
Table 99. Middle East and Africa Companion Animal Vaccines Sales by Type (2023-2028) & (K Units)
Table 100. Middle East and Africa Companion Animal Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Companion Animal Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Companion Animal Vaccines Sales by Application (2017-2022) & (K Units)
Table 103. Middle East and Africa Companion Animal Vaccines Sales by Application (2023-2028) & (K Units)
Table 104. Middle East and Africa Companion Animal Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Companion Animal Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 106. Middle East and Africa Companion Animal Vaccines Sales by Country (2017-2022) & (K Units)
Table 107. Middle East and Africa Companion Animal Vaccines Sales by Country (2023-2028) & (K Units)
Table 108. Middle East and Africa Companion Animal Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 109. Middle East and Africa Companion Animal Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 110. Bayer Corporation Information
Table 111. Bayer Description and Major Businesses
Table 112. Bayer Companion Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. Bayer Companion Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Bayer Recent Developments
Table 115. Vetoquinol Corporation Information
Table 116. Vetoquinol Description and Major Businesses
Table 117. Vetoquinol Companion Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. Vetoquinol Companion Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Vetoquinol Recent Developments
Table 120. Boehringer Ingelheim Corporation Information
Table 121. Boehringer Ingelheim Description and Major Businesses
Table 122. Boehringer Ingelheim Companion Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Boehringer Ingelheim Companion Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Boehringer Ingelheim Recent Developments
Table 125. Ceva Corporation Information
Table 126. Ceva Description and Major Businesses
Table 127. Ceva Companion Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. Ceva Companion Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Ceva Recent Developments
Table 130. Eli Lilly Corporation Information
Table 131. Eli Lilly Description and Major Businesses
Table 132. Eli Lilly Companion Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 133. Eli Lilly Companion Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Eli Lilly Recent Developments
Table 135. Heska Corporation Information
Table 136. Heska Description and Major Businesses
Table 137. Heska Companion Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 138. Heska Companion Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Heska Recent Developments
Table 140. Merck Corporation Information
Table 141. Merck Description and Major Businesses
Table 142. Merck Companion Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 143. Merck Companion Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Merck Recent Developments
Table 145. Merial Corporation Information
Table 146. Merial Description and Major Businesses
Table 147. Merial Companion Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 148. Merial Companion Animal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Merial Recent Developments
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Companion Animal Vaccines Distributors List
Table 153. Companion Animal Vaccines Customers List
Table 154. Companion Animal Vaccines Market Trends
Table 155. Companion Animal Vaccines Market Drivers
Table 156. Companion Animal Vaccines Market Challenges
Table 157. Companion Animal Vaccines Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Companion Animal Vaccines Product Picture
Figure 3. Global Companion Animal Vaccines Market Share by Type in 2021 & 2028
Figure 3. Attenuated Live Vaccines Product Picture
Figure 4. Conjugate Vaccines Product Picture
Figure 5. Inactivated Vaccines Product Picture
Figure 6. Subunit Vaccines Product Picture
Figure 7. Toxoid Vaccines Product Picture
Figure 8. DNA Vaccines Product Picture
Figure 9. Recombinant Vaccines Product Picture
Figure 10. Global Companion Animal Vaccines Market Share by Application in 2021 & 2028
Figure 11. Canine
Figure 12. Avian
Figure 13. Feline
Figure 14. Companion Animal Vaccines Report Years Considered
Figure 15. Global Companion Animal Vaccines Sales 2017-2028 (K Units)
Figure 16. Global Companion Animal Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Companion Animal Vaccines Revenue 2017-2028 (US$ Million)
Figure 18. Global Companion Animal Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 19. Global Companion Animal Vaccines Sales Market Share by Region (2017-2022)
Figure 20. Global Companion Animal Vaccines Sales Market Share by Region (2023-2028)
Figure 21. North America Companion Animal Vaccines Sales YoY (2017-2028) & (K Units)
Figure 22. North America Companion Animal Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Europe Companion Animal Vaccines Sales YoY (2017-2028) & (K Units)
Figure 24. Europe Companion Animal Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Asia-Pacific Companion Animal Vaccines Sales YoY (2017-2028) & (K Units)
Figure 26. Asia-Pacific Companion Animal Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Latin America Companion Animal Vaccines Sales YoY (2017-2028) & (K Units)
Figure 28. Latin America Companion Animal Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Middle East & Africa Companion Animal Vaccines Sales YoY (2017-2028) & (K Units)
Figure 30. Middle East & Africa Companion Animal Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 31. The Companion Animal Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 32. The Top 5 and 10 Largest Manufacturers of Companion Animal Vaccines in the World: Market Share by Companion Animal Vaccines Revenue in 2021
Figure 33. Global Companion Animal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 34. Global Companion Animal Vaccines Sales Market Share by Type (2017-2028)
Figure 35. Global Companion Animal Vaccines Revenue Market Share by Type (2017-2028)
Figure 36. Global Companion Animal Vaccines Sales Market Share by Application (2017-2028)
Figure 37. Global Companion Animal Vaccines Revenue Market Share by Application (2017-2028)
Figure 38. North America Companion Animal Vaccines Sales Market Share by Type (2017-2028)
Figure 39. North America Companion Animal Vaccines Revenue Market Share by Type (2017-2028)
Figure 40. North America Companion Animal Vaccines Sales Market Share by Application (2017-2028)
Figure 41. North America Companion Animal Vaccines Revenue Market Share by Application (2017-2028)
Figure 42. North America Companion Animal Vaccines Sales Share by Country (2017-2028)
Figure 43. North America Companion Animal Vaccines Revenue Share by Country (2017-2028)
Figure 44. U.S. Companion Animal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 45. Canada Companion Animal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 46. Europe Companion Animal Vaccines Sales Market Share by Type (2017-2028)
Figure 47. Europe Companion Animal Vaccines Revenue Market Share by Type (2017-2028)
Figure 48. Europe Companion Animal Vaccines Sales Market Share by Application (2017-2028)
Figure 49. Europe Companion Animal Vaccines Revenue Market Share by Application (2017-2028)
Figure 50. Europe Companion Animal Vaccines Sales Share by Country (2017-2028)
Figure 51. Europe Companion Animal Vaccines Revenue Share by Country (2017-2028)
Figure 52. Germany Companion Animal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 53. France Companion Animal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 54. U.K. Companion Animal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 55. Italy Companion Animal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 56. Russia Companion Animal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 57. Asia Pacific Companion Animal Vaccines Sales Market Share by Type (2017-2028)
Figure 58. Asia Pacific Companion Animal Vaccines Revenue Market Share by Type (2017-2028)
Figure 59. Asia Pacific Companion Animal Vaccines Sales Market Share by Application (2017-2028)
Figure 60. Asia Pacific Companion Animal Vaccines Revenue Market Share by Application (2017-2028)
Figure 61. Asia Pacific Companion Animal Vaccines Sales Share by Region (2017-2028)
Figure 62. Asia Pacific Companion Animal Vaccines Revenue Share by Region (2017-2028)
Figure 63. China Companion Animal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 64. Japan Companion Animal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 65. South Korea Companion Animal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 66. India Companion Animal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 67. Australia Companion Animal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 68. Taiwan Companion Animal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 69. Indonesia Companion Animal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 70. Thailand Companion Animal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 71. Malaysia Companion Animal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 72. Philippines Companion Animal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 73. Latin America Companion Animal Vaccines Sales Market Share by Type (2017-2028)
Figure 74. Latin America Companion Animal Vaccines Revenue Market Share by Type (2017-2028)
Figure 75. Latin America Companion Animal Vaccines Sales Market Share by Application (2017-2028)
Figure 76. Latin America Companion Animal Vaccines Revenue Market Share by Application (2017-2028)
Figure 77. Latin America Companion Animal Vaccines Sales Share by Country (2017-2028)
Figure 78. Latin America Companion Animal Vaccines Revenue Share by Country (2017-2028)
Figure 79. Mexico Companion Animal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 80. Brazil Companion Animal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 81. Argentina Companion Animal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 82. Middle East and Africa Companion Animal Vaccines Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Companion Animal Vaccines Revenue Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Companion Animal Vaccines Sales Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Companion Animal Vaccines Revenue Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Companion Animal Vaccines Sales Share by Country (2017-2028)
Figure 87. Middle East and Africa Companion Animal Vaccines Revenue Share by Country (2017-2028)
Figure 88. Turkey Companion Animal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 89. Saudi Arabia Companion Animal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 90. UAE Companion Animal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 91. Companion Animal Vaccines Value Chain
Figure 92. Companion Animal Vaccines Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount